TABLE OF CONTENTS

1. INTRODUCTION 15
1.1. OBJECTIVES OF THE STUDY 15
1.2. MARKET DEFINITION 15
1.3. OVERVIEW OF NORTH AMERICA CHOLESTEROL TESTING MARKET 15
1.4. CURRENCY AND PRICING 16
1.5. LIMITATION 16
1.6. MARKETS COVERED 17
2. MARKET SEGMENTATION 19
2.1. MARKETS COVERED 19
2.2. GEOGRAPHIC SCOPE 20
2.3. YEARS CONSIDERED FOR THE STUDY 21
2.4. CURRENCY AND PRICING 21
2.5. RESEARCH METHODOLOGY 22
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.7. SECONDARY SOURCES 26
2.8. ASSUMPTIONS 27
3. EXECUTIVE SUMMARY 28
4. MARKET OVERVIEW 31
4.1. DRIVERS 33
4.2. RESTRAINTS 34
4.3. OPPORTUNITIES 35
4.4. CHALLENGES 35
5. PREMIUM INSIGHTS 36
6. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY PRODUCT TYPE 37
6.1. OVERVIEW 38
6.2. TESTING STRIPS 40
6.3. TEST KITS 41
7. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY TEST 42
7.1. OVERVIEW 43
7.2. LIPID PANEL TEST/COMPLETE LIPID PROFILE 45
7.2.1. TOTAL CHOLESTEROL TEST 46
7.2.2. HDL CHOLESTEROL TEST 46
7.2.3. LDL CHOLESTEROL TEST 47
7.2.4. TRIGLYCERIDES/VLDL CHOLESTEROL TEST 47
7.3. APOLIPOPROTEIN B TEST 48
7.4. APOLIPOPROTEIN A-1 TEST 49
7.5. APOE GENOTYPING TEST 50
7.6. APOLIPOPROTEIN CII 51
7.7. OTHERS 52
8. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY TEST TYPE 53
8.1. OVERVIEW 54
8.2. NON-INVASIVE 56
8.3. INVASIVE 57
9. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY PRESCRIPTION MODE 58
9.1. OVERVIEW 59
9.2. OVER THE COUNTER 61
9.3. PRESCRIPTION BASED 62
10. NORTH AMERICA CHOLESTEROL TESTING MARKET, BY END-USERS 63
10.1. OVERVIEW 64
10.2. CLINICS 66
10.3. HOSPITALS 67
10.4. AMBULATORY CENTERS 68
10.5. HOMECARE 69
10.6. DIAGNOSTIC CENTERS 70
11. NORTH AMERICA CHOLESTEROL TESTING MARKET BY GEOGRAPHY 71
11.1. NORTH AMERICA 73
11.1.1. U.S. 83
11.1.2. CANADA 86
11.1.3. MEXICO 89
12. NORTH AMERICA CHOLESTEROL TESTING MARKET, COMPANY LANDSCAPE 93
12.1. COMPANY SHARE ANALYSIS; NORTH AMERICA 93
13. COMPANY PROFILES 94
13.1. BIO-RAD LABORATORIES, INC. 94
13.1.1. COMPANY OVERVIEW 94
13.1.2. BIO-RAD LABORATORIES, INC.; REVENUE ANALYSIS 94
13.1.3. PRODUCT PORTFOLIO 95
13.1.4. RECENT DEVELOPMENTS 95
13.2. ABBOTT 96
13.2.1. COMPANY OVERVIEW 96
13.2.2. ABBOTT; REVENUE ANALYSIS 96
13.2.3. PRODUCT PORTFOLIO 97
13.2.4. RECENT DEVELOPMENTS 97
13.3. SIEMENS AG 98
13.3.1. COMPANY OVERVIEW 98
13.3.2. SIEMENS AG; REVENUE ANALYSIS 98
13.3.3. PRODUCT PORTFOLIO 99
13.3.4. RECENT DEVELOPMENTS 99
13.4. ALERE INC. 100
13.4.1. COMPANY OVERVIEW 100
13.4.2. ALERE INC.; REVENUE ANALYSIS 100
13.4.3. PRODUCT PORTFOLIO 101
13.4.4. RECENT DEVELOPMENTS 101
13.5. SIGMA ALDRICH (A SUBSIDIARY OF MERCK KGAA) 102
13.5.1. COMPANY OVERVIEW 102
13.5.2. MERCK KGAA; REVENUE ANALYSIS 102
13.5.3. PRODUCT PORTFOLIO 103
13.5.4. RECENT DEVELOPMENTS 103
13.6. F. HOFFMANN-LA ROCHE LTD 104
13.6.1. COMPANY OVERVIEW 104
13.6.2. F. HOFFMANN-LA ROCHE LTD;REVENUE ANALYSIS 104
13.6.3. PRODUCT PORTFOLIO 105
13.6.4. RECENT DEVELOPMENTS 105
13.7. DANAHER 106
13.7.1. COMPANY OVERVIEW 106
13.7.2. DANAHER; REVENUE ANALYSIS 106
13.7.3. PRODUCT PORTFOLIO 107
13.7.4. RECENT DEVELOPMENTS 107
13.8. QUEST DIAGNOSTICS INCORPORATED 108
13.8.1. COMPANY OVERVIEW 108
13.8.2. QUEST DIAGNOSTICS INCORPORATED; REVENUE ANALYSIS 108
13.8.3. PRODUCT PORTFOLIO 109
13.8.4. RECENT DEVELOPMENTS 109
13.9. ACCUTECH, LLC 110
13.9.1. COMPANY OVERVIEW 110
13.9.2. ACCUTECH, LLC; COMPANY SNAPSHOT 110
13.9.3. PRODUCT PORTFOLIO 110
13.9.4. RECENT DEVELOPMENTS 110
13.10. PRIMA LAB SA 111
13.10.1. COMPANY OVERVIEW 111
13.10.2. PRIMA LAB SA; COMPANY SNAPSHOT 111
13.10.3. PRODUCT PORTFOLIO 111
13.10.4. RECENT DEVELOPMENTS 111
13.11. HOME ACCESS HEALTH CORPORATION 112
13.11.1. COMPANY OVERVIEW 112
13.11.2. HOME ACCESS HEALTH CORPORATION; COMPANY SNAPSHOT 112
13.11.3. PRODUCT PORTFOLIO 112
13.11.4. RECENT DEVELOPMENTS 112
13.12. EUROFINS SCIENTIFIC 113
13.12.1. COMPANY OVERVIEW 113
13.12.2. EUROFINS SCIENTIFIC; REVENUE ANALYSIS 113
13.12.3. PRODUCT PORTFOLIO 114
13.12.4. RECENT DEVELOPMENTS 114
13.13. RANDOX LABORATORIES LTD. 115
13.13.1. COMPANY OVERVIEW 115
13.13.2. RANDOX LABORATORIES LTD.; COMPANY SNAPSHOT 115
13.13.3. PRODUCT PORTFOLIO 115
13.13.4. RECENT DEVELOPMENTS 115
13.14. PTS DIAGNOSTICS 116
13.14.1. COMPANY OVERVIEW 116
13.14.2. PTS DIAGNOSTIC; COMPANY SNAPSHOT 116
13.14.3. PRODUCT PORTFOLIO 117
13.14.4. RECENT DEVELOPMENTS 117
14. RELATED REPORTS 118